HOSPICE OF THE GOOD SHEPHERD LTD
Financial health, per its FY2025 accounts
The accounts state that the charity reported a surplus of £717k for the year, driven by significant legacy income and a one-off donation, despite a net operating loss. Free reserves increased to £2.7m, which the trustees note represents 5.9 months of expenditure, exceeding their stated policy target of four months. The trustees acknowledge ongoing financial challenges due to insufficient statutory funding and rising costs, approving a deficit budget for the following year.
What the accounts disclose
“The aim of the charity is to maintain sufficient reserves to support four months’ running costs to accommodate any unexpected funding issues.” — page 41
“The Hospice of the Good Shepherd has one wholly owned subsidiary, Hospice of Good Shepherd Promotions Limited (Company Number 3350371).” — page 38
Structured financials (annual return, FY ending 31/03/2025)
Care Quality Commission ratings
- Hospice of the Good Shepherd: Outstanding
Trustees
- CAROLINE MARY ELIZABETH MOSLEYchair
- David Gilburt
- Dominic Strange
- Dr Elizabeth Redmond
- Dr Neil Fergusson
- Dr Susan Laura Freeman
- Gary Barr
- Lesley Mills
- Suzanne Crutchley
- Yvonne Emmett Cannell
Income and spending
| Financial year end | Income | Spending |
|---|---|---|
| 31/03/2025 | £6.1m | £5.5m |
| 31/03/2024 | £5.3m | £5.2m |
| 31/03/2023 | £4.6m | £4.9m |
| 31/03/2022 | £4.6m | £4.0m |
| 31/03/2021 | £4.1m | £3.6m |
Common questions
Is HOSPICE OF THE GOOD SHEPHERD LTD financially healthy?
The accounts state that the charity reported a surplus of £717k for the year, driven by significant legacy income and a one-off donation, despite a net operating loss. Free reserves increased to £2.7m, which the trustees note represents 5.9 months of expenditure, exceeding their stated policy target of four months. The trustees acknowledge ongoing financial challenges due to insufficient statutory funding and rising costs, approving a deficit budget for the following year. Its FY2025 accounts were audited by Xeinadin Audit Ltd..